Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel De Vos

Showing results (1-10 of 63) with videos related to

Pageof 7
Sort By:
Methods in Molecular Biology (Clifton, N.J.)|September 8, 2006
A review of current and future molecular diagnostic tests for use in the microbiology laboratoryGeert Jannes, Daniel De Vos
Methods in Molecular Biology (Clifton, N.J.)|November 10, 2017
Guidelines to Compose an Ideal Bacteriophage CocktailMaia Merabishvili, Jean-Paul Pirnay, Daniel De Vos
Methods in Molecular Biology (Clifton, N.J.)|December 8, 2023
Guidelines to Compose an Ideal Bacteriophage CocktailMaia Merabishvili, Jean-Paul Pirnay, Daniel De Vos
Methods in Molecular Biology (Clifton, N.J.)|December 8, 2023
Bacteriophage Production in Compliance with Regulatory RequirementsJean-Paul Pirnay, Maia Merabishvili, Daniel De Vos, et al.
Methods in Molecular Biology (Clifton, N.J.)|November 10, 2017
Bacteriophage Production in Compliance with Regulatory RequirementsJean-Paul Pirnay, Maia Merabishvili, Hilde Van Raemdonck, et al.
Future Microbiology|October 12, 2007
European regulatory conundrum of phage therapyGilbert Verbeken, Daniel De Vos, Mario Vaneechoutte, et al.
Environmental Microbiology|January 22, 2003
Analysis of the Pseudomonas aeruginosa oprD gene from clinical and environmental isolatesJean-Paul Pirnay, Daniel De Vos, Dimitris Mossialos, et al.
Applied and Environmental Microbiology|June 5, 2012
Effects of sequential and simultaneous applications of bacteriophages on populations of Pseudomonas aeruginosa in vitro and in wax moth larvaeAlex R Hall, Daniel De Vos, Ville-Petri Friman, et al.
Microbiology (Reading, England)|May 1, 1997
Molecular and immunological characterization of OprL, the 18 kDa outer-membrane peptidoglycan-associated lipoprotein (PAL) of Pseudomonas aeruginosaAntonio Lim, Daniel De Vos, Mathieu Brauns, et al.
Current Pharmaceutical Biotechnology|March 11, 2010
Phage therapy in clinical practice: treatment of human infectionsElizabeth Kutter, Daniel De Vos, Guram Gvasalia, et al.
Pageof 7

Showing results (1-10 of 63) with videos related to

Sort By:
Pageof 7
Methods in Molecular Biology (Clifton, N.J.)|September 8, 2006
A review of current and future molecular diagnostic tests for use in the microbiology laboratoryGeert Jannes, Daniel De Vos
Methods in Molecular Biology (Clifton, N.J.)|November 10, 2017
Guidelines to Compose an Ideal Bacteriophage CocktailMaia Merabishvili, Jean-Paul Pirnay, Daniel De Vos
Methods in Molecular Biology (Clifton, N.J.)|December 8, 2023
Guidelines to Compose an Ideal Bacteriophage CocktailMaia Merabishvili, Jean-Paul Pirnay, Daniel De Vos
Methods in Molecular Biology (Clifton, N.J.)|December 8, 2023
Bacteriophage Production in Compliance with Regulatory RequirementsJean-Paul Pirnay, Maia Merabishvili, Daniel De Vos, et al.
Methods in Molecular Biology (Clifton, N.J.)|November 10, 2017
Bacteriophage Production in Compliance with Regulatory RequirementsJean-Paul Pirnay, Maia Merabishvili, Hilde Van Raemdonck, et al.
Future Microbiology|October 12, 2007
European regulatory conundrum of phage therapyGilbert Verbeken, Daniel De Vos, Mario Vaneechoutte, et al.
Environmental Microbiology|January 22, 2003
Analysis of the Pseudomonas aeruginosa oprD gene from clinical and environmental isolatesJean-Paul Pirnay, Daniel De Vos, Dimitris Mossialos, et al.
Applied and Environmental Microbiology|June 5, 2012
Effects of sequential and simultaneous applications of bacteriophages on populations of Pseudomonas aeruginosa in vitro and in wax moth larvaeAlex R Hall, Daniel De Vos, Ville-Petri Friman, et al.
Microbiology (Reading, England)|May 1, 1997
Molecular and immunological characterization of OprL, the 18 kDa outer-membrane peptidoglycan-associated lipoprotein (PAL) of Pseudomonas aeruginosaAntonio Lim, Daniel De Vos, Mathieu Brauns, et al.
Current Pharmaceutical Biotechnology|March 11, 2010
Phage therapy in clinical practice: treatment of human infectionsElizabeth Kutter, Daniel De Vos, Guram Gvasalia, et al.
Pageof 7